2533
Oenon Holdings, Inc.
オエノンホールディングス株式会社Oenon Holdings, Inc. engages in the alcoholic beverages, enzymes pharmaceuticals, real estate, and other businesses based on biotechnologies derived from fermentation technologies in Japan. The company offers alcoholic beverages, including shochu, sake, chuhai, synthetic sake, plum wines/liqueurs, spirits, imported wines, and ready-to-drink alcoholic beverages, as well as alcoholic beverage ingredients, industrial alcohol, and seasonings. It also provides enzymes such as lactase, glucose isomerase, isoamylase, cellulase, and inulinase for food applications, as well as protease for food, research, and diagnostics. In addition, the company provides contract manufacturing services and engages in diagnostic medicines and outsourced fermentation businesses. Further, it is involved in the purchase, sale, and leasing of real estate, as well as warehousing, transportation, and cargo handling activities. Additionally, the company exports its products. Oenon Holdings, Inc. was incorporated in 1920 and is headquartered in Tokyo, Japan.
Price
¥491
Market Cap
¥27.7B
Ent. Value
¥29.3B
Net Debt
−¥1.7B
Shares Out.
56.3M
P / E
9.0×
EV / EBIT
7.1×
P / Book
1.06×
P / NCAV
N/M
Div. Yield
2.24%
Financials
| Metric |
FY 2025
EDINET ↗ |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|---|
| Net Sales | ¥87.6B | ¥84.1B | ¥84.9B | ¥81.1B | ¥78.6B |
| Cost of Sales | ¥72.2B | ¥70.1B | ¥71.0B | ¥71.4B | ¥66.0B |
| Gross Profit | ¥15.5B | ¥14.0B | ¥14.0B | ¥9.7B | ¥12.7B |
| SG&A | ¥11.3B | ¥10.5B | ¥10.4B | ¥10.4B | ¥11.4B |
| Operating Income | ¥4.1B | ¥3.4B | ¥3.6B | ¥-707M | ¥1.2B |
| Non-Operating Income | ¥400M | ¥345M | ¥254M | ¥186M | ¥167M |
| Dividend Income | ¥77M | ¥52M | ¥43M | ¥38M | ¥33M |
| Interest Income | ¥0M | ¥0M | ¥0M | ¥0M | ¥0M |
| Non-Operating Expenses | ¥245M | ¥163M | ¥137M | ¥124M | ¥106M |
| Interest Expense | ¥132M | ¥102M | ¥91M | ¥79M | ¥60M |
| Ordinary Income | ¥4.3B | ¥3.6B | ¥3.7B | ¥-645M | ¥1.3B |
| Pre-tax Income | ¥4.1B | ¥3.6B | ¥3.6B | ¥-777M | ¥464M |
| Income Taxes | ¥1.1B | ¥863M | ¥206M | ¥664M | ¥203M |
| Current Tax | ¥1.1B | ¥884M | ¥770M | ¥115M | ¥155M |
| Deferred Tax | ¥-24M | ¥-21M | ¥-563M | ¥548M | ¥48M |
| Net Income (owners) | ¥3.1B | ¥2.7B | ¥3.4B | ¥-1.3B | ¥299M |
| Minority Interest | ¥-35M | ¥0M | ¥4M | ¥-184M | ¥-37M |
| Comprehensive Income | ¥3.5B | ¥3.2B | ¥3.9B | ¥-1.7B | ¥399M |
| EBITDA | ¥6.1B | ¥5.4B | ¥5.4B | ¥1.0B | ¥2.9B |
| Goodwill Amort. (J-GAAP) | ¥1M | ¥2M | ¥2M | ¥2M | ¥2M |
| EPS | ¥54.72 | ¥47.39 | ¥58.30 | ¥-21.22 | ¥5.03 |
| Shares Outstanding | 56.3M | 57.0M | 58.2M | 58.2M | 59.4M |
| Shares Issued (total) | 65.6M | 65.6M | 65.6M | 65.6M | 65.6M |
| Treasury Shares | 9.2M | 8.6M | 7.4M | 7.4M | 6.2M |